163 related articles for article (PubMed ID: 16842374)
1. New targets and challenges in the molecular therapeutics of cancer.
Eastman A; Perez RP
Br J Clin Pharmacol; 2006 Jul; 62(1):5-14. PubMed ID: 16842374
[TBL] [Abstract][Full Text] [Related]
2. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
5. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
Rowinsky EK
J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
[TBL] [Abstract][Full Text] [Related]
6. Strategy for the development of novel anticancer drugs.
Saijo N; Tamura T; Nishio K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
[TBL] [Abstract][Full Text] [Related]
7. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
8. Targeting PI3K-AKT pathway for cancer therapy.
Lu Y; Wang H; Mills GB
Rev Clin Exp Hematol; 2003 Jun; 7(2):205-28. PubMed ID: 14763163
[TBL] [Abstract][Full Text] [Related]
9. Molecular-targeted therapies: lessons from years of clinical development.
Rosa DD; Ismael G; Lago LD; Awada A
Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
[TBL] [Abstract][Full Text] [Related]
10. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
11. [Problems associated with molecular targeted drugs for cancer].
Kawaishi M; Koizum F; Nishio K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1373-9. PubMed ID: 17033223
[TBL] [Abstract][Full Text] [Related]
12. [Molecular targeting drugs--present status and future development].
Kuwano M; Fujii T; Ono M; Izumi H; Kohno K
Nihon Rinsho; 2004 Jul; 62(7):1211-5. PubMed ID: 15283135
[TBL] [Abstract][Full Text] [Related]
13. Promising targets and drugs in development for colorectal cancer.
Thompson C; Leong S; Messersmith W
Semin Oncol; 2011 Aug; 38(4):588-97. PubMed ID: 21810518
[TBL] [Abstract][Full Text] [Related]
14. Early oncology clinical trial design in the era of molecular-targeted agents.
Brunetto AT; Kristeleit RS; de Bono JS
Future Oncol; 2010 Aug; 6(8):1339-52. PubMed ID: 20799878
[TBL] [Abstract][Full Text] [Related]
15. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
16. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
[TBL] [Abstract][Full Text] [Related]
17. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
Rossig C; Juergens H; Berdel WE
Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy: for kids, too.
Corey SJ
Pediatr Blood Cancer; 2005 Oct; 45(5):623-34. PubMed ID: 15704219
[TBL] [Abstract][Full Text] [Related]
19. Is there a future for Aurora kinase inhibitors for anticancer therapy?
Carpinelli P; Moll J
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
[TBL] [Abstract][Full Text] [Related]
20. Targeted cancer therapeutics.
Hait WN; Hambley TW
Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]